Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma

• Main Authors: María José Méndez-Vidal (Author), Áurea Molina (Author), Urbano Anido (Author), Isabel Chirivella (Author), Olatz Etxaniz (Author), Eva Fernández-Parra (Author), Marta Guix (Author), Carolina Hernández (Author), Julio Lambea (Author), Álvaro Montesa (Author), Álvaro Pinto (Author), Silverio Ros (Author), Enrique Gallardo (Author)
• Format: Book
• Published: BMC, 2018-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Pazopanib is indicated in the first-line treatment of metastatic renal cell cancer (mRCC). The aim of this study was to review the efficacy, safety, and pharmacokinetics of pazopanib and see how these aspects are linked to clinical practice. Methods A non-exhaustive systematic re...